Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vegetable Signature From Human Metabolomics Responses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03483558
Recruitment Status : Completed
First Posted : March 30, 2018
Last Update Posted : March 30, 2018
Sponsor:
Collaborators:
Academia Sinica, Taiwan
Tri-Service General Hospital
Fu Jen Catholic University
Information provided by (Responsible Party):
National Health Research Institutes, Taiwan

Brief Summary:
The purpose of this study is to perform dietary intervention studies on a variety of vegetables.

Condition or disease Intervention/treatment Phase
Vegetable Signature Documentation With Metabolomic Technique Other: Control Other: Spinach Other: Celery Other: Onion Other: Mixed Vegetables Not Applicable

Detailed Description:
Plant-based foods have always been an important component of a healthy diet. High intake of plant foods may not only maintain normal bodily functions through the provision of dietary fiber, vitamins, and minerals but also relieve symptoms and prevent diseases. Many studies have pointed out that high intake of plant foods may reduce the incidence of non-communicable disease. Past research investigating the effect of phytochemicals has usually been limited to single substances or single foods. However, a number of researchers have pointed out that phytonutrients and dietary components are likely to act synergistically.Health effects and mechanisms of phytonutrients in combination have not been carefully studied in population settings. The technology of metabolomics has enabled the simultaneous measurement of hundreds of small molecules in biological samples. Exploring the change of metabolites after feeding can not only help us understand the role of plant foods, but may also provide opportunities to assess plant food intake levels.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 13 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Dietary Intervention Studies on a Variety of Vegetables
Actual Study Start Date : June 11, 2011
Actual Primary Completion Date : December 31, 2012
Actual Study Completion Date : May 28, 2015

Arm Intervention/treatment
Experimental: Control
Participants were fed a standardized diet (without any vegetables) in this experiment.
Other: Control
A standardized diet without any vegetables was provided.

Experimental: Spinach
Participants were fed a standardized diet with 200g spinach in this experiment.
Other: Spinach
A standardized diet with 200g spinach was provided.

Experimental: Celery
Participants were fed a standardized diet with 200g celery in this experiment.
Other: Celery
A standardized diet with 200g celery was provided.

Experimental: Onion
Participants were fed a standardized diet with 200g onion in this experiment.
Other: Onion
A standardized diet with 200g onion was provided.

Experimental: Mixed Vegetables
Participants were fed a standardized diet with 200g of mixed vegetables (spinach, celery, and onion) in this experiment.
Other: Mixed Vegetables
A standardized diet with 200g of mixed vegetables (spinach, celery, and onion) was provided.




Primary Outcome Measures :
  1. Intensities of multiple serum metabolites [ Time Frame: Baseline (fasting state before breakfast at 7:30AM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  2. Intensities of multiple serum metabolites [ Time Frame: 4 Hours (immediately before lunch at 11:30AM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  3. Intensities of multiple serum metabolites [ Time Frame: 5.5 hours (after lunch at 13:00PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  4. Intensities of multiple serum metabolites [ Time Frame: 6.5 hours (after lunch at 14:00 PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  5. Intensities of multiple serum metabolites [ Time Frame: 7.5 hours (after lunch at 15:00PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  6. Intensities of multiple serum metabolites [ Time Frame: 8.5 hours (after lunch at 16:00PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  7. Intensities of multiple serum metabolites [ Time Frame: 9.5 hours (after lunch at 17:00PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  8. Intensities of multiple serum metabolites [ Time Frame: 10.5 hours (after lunch at 18:00PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  9. Intensities of multiple serum metabolites [ Time Frame: 11.5 hours (after lunch at 19:00PM) ]
    The outcome measure consists of intensities of multiple serum metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  10. Intensities of multiple urinary metabolites [ Time Frame: Baseline (overnight urine sample collected at 7:30AM) ]
    The outcome measure consists of intensities of multiple urinary metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  11. Intensities of multiple urinary metabolites [ Time Frame: 3.5~4 hours (before lunch urine sample collected during 11:00~11:30AM) ]
    The outcome measure consists of intensities of multiple urinary metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  12. Intensities of multiple urinary metabolites [ Time Frame: 4.5~6.5 hours (2-hour after lunch urine sample collected from 12:00 to 14:00PM) ]
    The outcome measure consists of intensities of multiple urinary metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  13. Intensities of multiple urinary metabolites [ Time Frame: 6.5~8.5 hours (4-hour after lunch urine sample collected from 14:00 to 16:00PM) ]
    The outcome measure consists of intensities of multiple urinary metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.

  14. Intensities of multiple urinary metabolites [ Time Frame: 8.5~11.5 hours (7-hour after lunch urine sample collected from 16:00 to 19:00PM) ]
    The outcome measure consists of intensities of multiple urinary metabolites from a liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) experiment. Intensity means the level of response variable (a given metabolite) showing the degree of response detected by LC/TOF/MS.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI 18.5~30 kg/m2
  • non-smoker
  • non-alcoholic

Exclusion Criteria:

  • Unwilling to stop taking the dietary supplements that may affect the experiment result.
  • Unwilling to take the provided meal during the designated period.
  • Taking hypertension or diabetes drugs.
  • Diagnosed immune diseases (such as allergic diseases, autoimmune diseases, etc.), liver diseases, metabolic diseases (such as hyperthyroidism or hypothyroidism), or other not suitable for the dietary study.
  • Diagnosed cancer or other severe diseases.
  • Suffered from urinary tract infection or took antibiotic in the past three months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03483558


Sponsors and Collaborators
National Health Research Institutes, Taiwan
Academia Sinica, Taiwan
Tri-Service General Hospital
Fu Jen Catholic University
Investigators
Layout table for investigator information
Principal Investigator: Wen-Harn Pan, Ph.D. National Health Research Institutes, Taiwan
Layout table for additonal information
Responsible Party: National Health Research Institutes, Taiwan
ClinicalTrials.gov Identifier: NCT03483558    
Other Study ID Numbers: NHRI_EC0991003
First Posted: March 30, 2018    Key Record Dates
Last Update Posted: March 30, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by National Health Research Institutes, Taiwan:
vegetable metabolite signature
human serum/urinary metabolite
liquid chromatography mass spectrometry